HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom H Johnston Selected Research

Neuroprotective Agents

1/2006Drugs in development for Parkinson's disease: an update.
7/2004Drugs in development for Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom H Johnston Research Topics

Disease

45Parkinson Disease (Parkinson's Disease)
01/2021 - 02/2005
36Dyskinesias (Dyskinesia)
01/2021 - 07/2004
7Parkinsonian Disorders (Parkinsonism)
01/2019 - 11/2006
5Psychotic Disorders (Schizoaffective Disorder)
07/2014 - 09/2006
3Chorea (Rheumatic Chorea)
06/2011 - 06/2006
3Dystonia (Limb Dystonia)
06/2011 - 06/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 07/2008
2Synucleinopathies
01/2019 - 01/2016
2Disease Progression
01/2006 - 07/2004
1Cognitive Dysfunction
01/2021
1Huntington Disease (Huntington's Disease)
01/2019
1Diabetes Mellitus
03/2015
1Alternating hemiplegia of childhood
01/2013
1Hallucinations (Hallucination)
05/2012
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
02/2011
1Catalepsy
09/2008
1Atrophy
07/2008

Drug/Important Bio-Agent (IBA)

36Levodopa (L Dopa)FDA LinkGeneric
01/2021 - 07/2004
201- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2019 - 06/2006
10Dopamine (Intropin)FDA LinkGeneric
01/2021 - 06/2010
3Amantadine (Aman)FDA LinkGeneric
11/2018 - 11/2006
3alpha-SynucleinIBA
01/2016 - 10/2010
35-HT1A Serotonin ReceptorIBA
10/2015 - 01/2012
3Pharmaceutical PreparationsIBA
08/2015 - 11/2005
3Dopamine Agents (Dopaminergic Agents)IBA
10/2013 - 09/2008
2oxidized low density lipoproteinIBA
01/2018 - 03/2013
2Serotonin (5 Hydroxytryptamine)IBA
10/2015 - 07/2014
23- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA
02/2015 - 08/2012
2N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA
07/2014 - 01/2012
2N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2012 - 05/2011
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
05/2012 - 01/2012
2Quetiapine Fumarate (Seroquel)FDA Link
05/2012 - 11/2006
2Clozapine (Clozaril)FDA LinkGeneric
05/2012 - 11/2006
2Antipsychotic Agents (Antipsychotics)IBA
05/2012 - 11/2006
2Oxidopamine (6 Hydroxydopamine)IBA
01/2011 - 04/2008
2Haloperidol (Haldol)FDA LinkGeneric
09/2008 - 11/2006
2Neuroprotective AgentsIBA
01/2006 - 07/2004
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2021
1DisaccharidesIBA
01/2019
1pridopidineIBA
01/2019
1TrehaloseIBA
01/2019
1Capsules (Microcapsules)IBA
11/2018
1N-Methylaspartate (NMDA)IBA
11/2018
1DPI-289IBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2018
1Narcotic Antagonists (Opioid Antagonists)IBA
01/2018
13- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
10/2015
1Biomarkers (Surrogate Marker)IBA
08/2015
1PPAR gammaIBA
03/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2015
1Pioglitazone (Actos)FDA Link
03/2015
1Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
02/2015
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2013
1TC-8831IBA
10/2013
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
03/2013
1entacapone (Comtan)FDA Link
03/2013
1N- (6- (2- aminophenylamino)- 6- oxohexyl)- 4- methylbenzamideIBA
02/2013
1Histone Deacetylase InhibitorsIBA
02/2013
1Adenosine Triphosphatases (ATPase)IBA
01/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1Illicit Drugs (Recreational Drugs)IBA
05/2012
11- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazineIBA
05/2012
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2012
1KetanserinIBA
01/2012
1Naltrexone (ReVia)FDA LinkGeneric
06/2011
1mu Opioid Receptors (mu Opioid Receptor)IBA
06/2011
1Dihydroxyphenylalanine (Dopa)IBA
06/2011
1Dihydrotachysterol (AT 10)IBA
06/2011
1cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
02/2011
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
02/2011
1Proteins (Proteins, Gene)FDA Link
10/2010
1Histamine (Histamine Dihydrochloride)FDA Link
07/2010
1Famotidine (Pepcid)FDA LinkGeneric
07/2010
1Metabotropic Glutamate 5 ReceptorIBA
06/2010
1pyridineIBA
06/2010
1NociceptinIBA
10/2008
1J 113397IBA
10/2008
1Adenosine (Adenocard)FDA LinkGeneric
09/2008
11-aminocyclopentane-1,3,4-tricarboxylic acidIBA
09/2008
1Adenosine A2 Receptor AntagonistsIBA
09/2008
1Glutamic Acid (Glutamate)FDA Link
09/2008
1sarsasapogeninIBA
07/2008
1Nerve Growth Factors (Neurotrophins)IBA
07/2008
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2008
1Receptor Activity-Modifying Protein 1IBA
04/2008
1ApomorphineFDA Link
11/2006
1Dopamine Agonists (Dopamine Agonist)IBA
09/2006
1imetitIBA
06/2006
1Histamine AgonistsIBA
06/2006
14-(1H-imidazol-4-ylmethyl)piperidineIBA
06/2006
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
06/2006

Therapy/Procedure

12Therapeutics
01/2021 - 11/2006